Prevalence of polypharmacy and associated side effects in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis

Prevalence of polypharmacy and associated side effects in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis

Objectives Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic condition often accompanied by multiple comorbidities requiring complex pharmacological management. This review aims to examine the prevalence of polypharmacy in patients with MASLD, alongside an explo...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajna Golubic, Peter Fitzgerald, Sumantra Ray, Sarah Armes, Jenneffer Tibaes, Ramya Rajaram, Mark W Ruddock, Mary Jo Kurth
Format: Article
Language:English
Published: BMJ Publishing Group
Series:BMJ Nutrition, Prevention & Health
Online Access:https://nutrition.bmj.com/content/early/2025/07/23/bmjnph-2025-001236.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items